First approved for type 2 diabetes treatment, GLP-1s are also FDA-approved for obesity
Endocrine Practice , 22(Suppl 3), 1-203
But in the short time theyve been on the market, theyve demonstrated some serious issues that require further examination and study, specifically around how they are used, and how they affect overall health
Announcements Readout of Phase 3 Semaglutide Trials Marks Critical Moment in Alzheimers Research and Suggests Potential for Combination Therapies Today, Novo Nordisk released topline results from their phase 3 Evoke and Evoke+ trials of semaglutide, an oral GLP-1 drug, in individuals with early-stage Alzheimers disease, showing the trials did not meet their primary endpoints
Take the First Step Towards Effective Weight Loss Expert advice on Wegovy storage and usage Tailored solutions to support your weight loss journey Access to UK-licensed professionals for personalised guidance How Wegovy Injection Works in the Body Wegovy Injection contains semaglutide, which mimics a natural hormone involved in appetite regulation